KCNA3 and Huntington disease: Fortunately, over the years we have identified some key events that exacerbate certain disorders, such as the downregulation of potassium channel Kir4.1, or glutamate transporter, Glt1, in Huntington’s disease and amyloid lateral sclerosis[8, 17].